{
  "id": 9663727,
  "title": "Regulator mulls digital platform for drugmakers' test reports",
  "url": "https://urgent.news/2026/09/25/regulator-mulls-digital-platform-for-drugmakers-test-reports",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T00:30:19.000Z",
  "source": {
    "name": "Live Mint",
    "slug": "live-mint",
    "url": "https://www.livemint.com/news/india/apex-drugs-regulator-in-digital-platform-drugs-test-reports-pharma-healthcare-11790245889517.html"
  },
  "original_language": "en",
  "account": "New Delhi: India's drug regulator is considering the creation of a digital platform to showcase batch-level quality-test reports of medicines produced by pharmaceutical companies, according to two sources and a government communication to the Central Drugs Standard Control Organisation (CDSCO). This proposed system would contrast the current process of only alerting consumers when drugs fail quality checks through monthly not-of-standard-quality notices. By making routine batch-test reports publicly available, the plan aims to increase transparency and build trust among Indian consumers regarding the quality of medicines. The idea was raised during a meeting chaired by the Drugs Controller General of India (DCGI) in September, following the Kota hospital incident in May where five women died after receiving spurious oxytocin injections. With over 3,000 drug companies and 10,500 manufacturing facilities operating in India, the regulator's push for transparency is part of its ongoing efforts. India's top drugs regulator also plans to release inspection findings of pharma factories in the near future. Currently, manufacturers must pass quality tests before releasing a product for sale, but they are not required to share these results with intermediaries in the drug supply chain. The plan suggests amending the Drugs and Cosmetics Act, 1940 and Rules thereunder, 1945 to create a digital platform for public access to quality-testing reports. However, industry experts caution against the feasibility of such a move, suggesting that authorities should first focus on addressing not-of-standard-quality products and implementing effective drug recall mechanisms.",
  "summary": "To improve transparency, India's drug regulator is developing a digital platform that will allow consumers to view batch-level quality-test reports of medications.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}